Kanawha Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $906K | Sell |
1,844
-10
| -0.5% | -$5.43K | 0.06% | 137 |
|
|
2025
Q4 | $1.07M | Sell |
1,854
-82
| -4% | -$46.4K | 0.07% | 118 |
|
|
2025
Q3 | $939K | Sell |
1,936
-91
| -4% | -$42.4K | 0.07% | 129 |
|
|
2025
Q2 | $822K | Sell |
2,027
-6
| -0.3% | -$2.51K | 0.06% | 131 |
|
|
2025
Q1 | $1.01M | Sell |
2,033
-4
| -0.2% | -$2.17K | 0.08% | 118 |
|
|
2024
Q4 | $1.06M | Sell |
2,037
-15
| -0.7% | -$8.25K | 0.08% | 112 |
|
|
2024
Q3 | $1.27M | Sell |
2,052
-25
| -1% | -$14.8K | 0.09% | 114 |
|
|
2024
Q2 | $1.15M | Buy |
2,077
+99
| +5% | +$56.7K | 0.09% | 117 |
|
|
2024
Q1 | $1.15M | Sell |
1,978
-122
| -6% | -$68.5K | 0.09% | 116 |
|
|
2023
Q4 | $1.11M | Sell |
2,100
-38
| -2% | -$18.4K | 0.1% | 106 |
|
|
2023
Q3 | $1.08M | Sell |
2,138
-67
| -3% | -$35.7K | 0.1% | 103 |
|
|
2023
Q2 | $1.15M | Sell |
2,205
-63
| -3% | -$34K | 0.11% | 103 |
|
|
2023
Q1 | $1.31M | Sell |
2,268
-92
| -4% | -$51.9K | 0.13% | 97 |
|
|
2022
Q4 | $1.3M | Sell |
2,360
-30
| -1% | -$15.9K | 0.13% | 97 |
|
|
2022
Q3 | $1.21M | Buy |
2,390
+48
| +2% | +$26.9K | 0.13% | 96 |
|
|
2022
Q2 | $1.27M | Buy |
2,342
+37
| +2% | +$20.4K | 0.13% | 95 |
|
|
2022
Q1 | $1.36M | Sell |
2,305
-2
| -0.1% | -$1.15K | 0.12% | 98 |
|
|
2021
Q4 | $1.54M | Sell |
2,307
-37
| -2% | -$23.1K | 0.13% | 95 |
|
|
2021
Q3 | $1.34M | Sell |
2,344
-9
| -0.4% | -$4.94K | 0.12% | 98 |
|
|
2021
Q2 | $1.19M | Sell |
2,353
-40
| -2% | -$18.9K | 0.11% | 106 |
|
|
2021
Q1 | $1.09M | Buy |
2,393
+6
| +0.3% | +$2.86K | 0.11% | 106 |
|
|
2020
Q4 | $1.11M | Buy |
2,387
+5
| +0.2% | +$2.34K | 0.11% | 102 |
|
|
2020
Q3 | $1.05M | Hold |
2,382
| – | – | 0.12% | 93 |
|
|
2020
Q2 | $863K | Sell |
2,382
-25
| -1% | -$8.38K | 0.11% | 102 |
|
|
2020
Q1 | $683K | Sell |
2,407
-235
| -9% | -$74.1K | 0.1% | 100 |
|
|
2019
Q4 | $858K | Buy |
2,642
+1,605
| +155% | +$487K | 0.1% | 106 |
|
|
2019
Q3 | $302K | Hold |
1,037
| – | – | 0.04% | 156 |
|
|
2019
Q2 | $305K | Buy |
1,037
+10
| +1% | +$2.75K | 0.04% | 154 |
|
|
2019
Q1 | $281K | Hold |
1,027
| – | – | 0.04% | 146 |
|
|
2018
Q4 | $230K | Hold |
1,027
| – | – | 0.04% | 156 |
|
|
2018
Q3 | $251K | Hold |
1,027
| – | – | 0.03% | 158 |
|
|
2018
Q2 | $213K | Hold |
1,027
| – | – | 0.03% | 167 |
|
|
2018
Q1 | $212K | Buy |
+1,027
| New | +$216K | 0.03% | 166 |
|
Other funds holding TMO
VCM
Kanawha Capital Management's TMO Position: Q1 2026 in Review
Kanawha Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.54% in Q1 2026, selling an estimated $5.43K and leaving 1,844 shares worth $906K. The position accounts for 0.06% of the portfolio, ranked #137.
Kanawha Capital Management first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $1.54M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Kanawha Capital Management held 1,844 shares of Thermo Fisher Scientific worth $906K as of Q1 2026.
- Kanawha Capital Management sold 10 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.43K.
- Thermo Fisher Scientific made up 0.06% of Kanawha Capital Management's portfolio in Q1 2026, its #137 holding.
- Kanawha Capital Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Kanawha Capital Management's Thermo Fisher Scientific position peaked at $1.54M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Kanawha Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.